Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
25.55
+0.85 (3.44%)
At close: Jan 19, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 2.72 billion as of January 23, 2026. Its market cap has increased by 40.10% in one year.
Market Cap
2.72B
Enterprise Value
1.94B
Revenue
196.76M
Ranking
n/a
PE Ratio
59.69
Stock Price
25.55
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 2.72B, a decrease of -54.58%. That is a compound annual growth rate of -18.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 2.72B | 15.39% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Landfar Bio-medicine | 3.07B |
| Jiangsu CoWin Biotech | 3.06B |
| Shanghai Universal Biotech | 2.80B |
| Shandong Sito Bio-technology | 2.74B |
| Jiangsu Sihuan Bioengineering | 2.72B |
| Jilin Jian Yisheng Pharmaceutical | 2.70B |
| Zhejiang East Asia Pharmaceutical | 2.58B |
| Jiangsu Gdk Biological Technology | 2.53B |